Yih Ho, PhD - Publications

Affiliations: 
1984- College of Pharmacy Taipei Medical University 

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Lin SJ, Tai L, Huang YJ, Uang YS, Ho Y, Hsu KY, Wang LH. Effect of catechin and commercial preparation of green tea essence on the pharmacokinetics of L-dopa in rabbits. Biomedical Chromatography : Bmc. e5227. PMID 34388856 DOI: 10.1002/bmc.5227  0.52
2021 Chang SF, Liu HL, Ho Y, Yang LM, Tsai YE, Chou BH, Wang SH, Lin SJ. Transformation of 15-ene steviol by Aspergillus niger, Cunninghamella bainieri, and Mortierella isabellina. Phytochemistry. 187: 112776. PMID 33933828 DOI: 10.1016/j.phytochem.2021.112776  0.615
2019 Ho Y, Wu CY, Chin YT, Li ZL, Pan YS, Huang TY, Su PY, Lee SY, Crawford DR, Su KW, Chiu HC, Shih YJ, Changou CA, Yang YSH, Whang-Peng J, et al. NDAT suppresses pro-inflammatory gene expression to enhance resveratrol-induced anti-proliferation in oral cancer cells. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. 111092. PMID 31883986 DOI: 10.1016/j.fct.2019.111092  0.319
2019 Chang C, Ho Y, Lin S, Liu H. Discovery of Novel N-Glycoside and Non-Glycoside hSGLT2 Inhibitors for the Treatment of Type 2 Diabetes Mellitus Journal of Diabetes Mellitus. 9: 77-104. DOI: 10.4236/Jdm.2019.93009  0.314
2019 Tang J, Ho Y, Chang C, Liu H. Discovery of Novel Irreversible HER2 Inhibitors for Breast Cancer Treatment Journal of Biomedical Science and Engineering. 12: 225-244. DOI: 10.4236/Jbise.2019.124016  0.326
2018 Ho Y, Chen YF, Wang LH, Hsu KY, Chin YT, Yang YSH, Wang SH, Chen YR, Shih YJ, Liu LF, Wang K, Whang-Peng J, Tang HY, Lin HY, Liu HL, et al. Inhibitory Effect of Extract on Hyperglycemia-Related Expression and Cancer Proliferation. Frontiers in Pharmacology. 9: 807. PMID 30116189 DOI: 10.3389/fphar.2018.00807  0.612
2018 Ho Y, Sh Yang YC, Chin YT, Chou SY, Chen YR, Shih YJ, Whang-Peng J, Changou CA, Liu HL, Lin SJ, Tang HY, Lin HY, Davis PJ. Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R. Food and Chemical Toxicology : An International Journal Published For the British Industrial Biological Research Association. PMID 30026090 DOI: 10.1016/j.fct.2018.07.030  0.643
2018 Chin YT, Wei PL, Ho Y, Nana AW, Changou CA, Chen YR, Yang YS, Hsieh MT, Hercbergs A, Davis PJ, Shih YJ, Lin HY. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells. Endocrine-Related Cancer. PMID 29555649 DOI: 10.1530/ERC-17-0376  0.313
2007 Chen SM, Fan MY, Tseng CC, Ho Y, Hsu KY. Pharmacokinetics and nephrotoxicity of aristolochic acid in rabbits. Toxicon : Official Journal of the International Society On Toxinology. 50: 180-8. PMID 17512963 DOI: 10.1016/j.toxicon.2007.03.011  0.693
Show low-probability matches.